Senior Strategic Programs Manager, Ceribell

$175-185k

+ Annual Bonus Opportunity + Ceribell Equity

Google Analytics
Excel
Salesforce
Alteryx
Mid and Senior level
San Francisco Bay Area

Office located in Sunnyvale, CA

Ceribell

Portable seizure diagnostics technology

Open for applications

Ceribell

Portable seizure diagnostics technology

201-500 employees

HealthcareB2BArtificial IntelligenceMachine LearningMedTech

Open for applications

$175-185k

+ Annual Bonus Opportunity + Ceribell Equity

Google Analytics
Excel
Salesforce
Alteryx
Mid and Senior level
San Francisco Bay Area

Office located in Sunnyvale, CA

201-500 employees

HealthcareB2BArtificial IntelligenceMachine LearningMedTech

Company mission

To make EEG widely accessible, more efficient, and more cost-effective to improve the diagnosis and treatment of patients at risk for seizure.

Role

Who you are

  • 3 years of management consulting or investment banking experience​
  • Ideally 3 years of commercial med tech experience​
  • Managed small teams to successful outcomes​
  • Skilled in analytic tools (Excel, Altyrx) and commercial enablement platforms (SFDC, Groove, Adobe, Google Analytics, etc.)​
  • Bachelor’s degree, MBA/MS preferred​
  • Medical device / Healthcare experience preferred

What the job involves

  • Lead efforts on new business development and commercial programs to develop the market for non-convulsive seizure detection in acute care
  • Develop new commercial programs with direct impact in the non convulsive seizure market​
  • Conduct market analytics to define total opportunity and link with core business metrics to define success​
  • Develop program plans, including the detailed steps required to implement​
  • Manage implementation of key strategic programs in concert with executive sponsor(s)​
  • Work cross functionally to ensure success of key programs

Our take

Ceribell has created a cloud-based, AI-enabled electroencephalography (EEG) headset which helps diagnose seizures without the presence of an EEG technologist or specialist interpreter, allowing for faster diagnosis and better treatment.

Though founded back in 2014, Ceribell experienced a huge breakthrough in 2022 when its system was granted FDA clearance to help diagnose suspected seizures, which has led to a boost in venture capital investment.

The company has also gone on to receive the FDA’s Breakthrough Device Designation for its ability to diagnose delirium, or acute brain failure. Ceribell has no plans on stopping there though, and intends to grow its team rapidly in a bid to expand its tech capabilities for a range of other neurological conditions.

Steph headshot

Steph

Company Specialist

Insights

Led by a woman
Top investors

Few candidates hear
back within 2 weeks

46% employee growth in 12 months

Company

Funding (last 2 of 4 rounds)

Sep 2022

$50m

SERIES C

Apr 2021

$53m

SERIES C

Total funding: $151m

Company benefits

  • 100% Employer Paid Health, Dental and Vision for the Employee
  • 50%- 70% Employer Paid Heath, Dental and Vision for dependents (according to plan selection)
  • Ceribell equity
  • A flexible vacation policy and 11 paid holidays
  • Monthly cell phone reimbursement
  • Flex spending account, life insurance, and disability insurance
  • Excellent parental leave policy
  • Joining a mission minded organization!

Company values

  • Transformative – The Ceribell team aspires to be a changing force within healthcare, bringing disruptive technologies to market and improving diagnostics and treatment. To achieve our goals, we relentlessly push boundaries and are always action oriented
  • Patient Focused – We care about each and every patient our products touch because we know every life is precious. We are committed to making a positive impact on healthcare one family at a time
  • Passionate – We are passionate about the roles we play individually and collectively. Ceribell fosters an environment that advances both the personal and professional growth of our team members, while also embracing the differences within our community

Company HQ

Sunnyvale West, Sunnyvale, CA

Leadership

Xingjuan (Jane) Chao

(Co-founder & CEO)

Ph.D. in biophysics from Cornell University. Former Management Consultant with McKinsey & Company, later joining Novartis as Senior Strategy Manager. Principal Manager of Portfolio Management Strategy at Genentech before co-founding Ceribell.

Josef Parvizi

(Co-founder & Chairman)

Professor of Neurology at Stanford University School of Medicine since 2007. Previously worked in Internal Medicine Intern at Mayo Clinic.

Chris Chafe

(Co-founder)

Composer, Cellist, and Researcher. Director of Stanford University's Center for Computer Research in Music and Acoustics (CCRMA), and Duca Family Professor of Humanities and Sciences.

Salary benchmarks

We don't have enough data yet to provide salary benchmarks for this role.

Submit your salary to help other candidates with crowdsourced salary estimates.

Share this job

View 5 more jobs at Ceribell